Developing innovative therapies for neuropsychiatric diseases, including schizophrenia
Investors 2
| Date | Name | Website |
| 20.09.2024 | Vida Ventu... | vidaventur... |
| - | Pontifax V... | pontifax.c... |
Mentions in press and media 2
| Date | Title | Description |
| 08.01.2025 | LB Pharmaceuticals Announces Positive Topline Results from Phase 2 Trial of LB-102 in Schizophrenia | - |
| - | LB Pharmaceuticals | “LB Pharmaceuticals – New hope for patients suffering from Schizophrenia” |